XML 35 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Associate Benefit Plan
12 Months Ended
Aug. 28, 2021
Associate Benefit Plan [Abstract]  
Associate Benefit Plan 12. ASSOCIATE BENEFIT PLANS

The Company accounts for all share-based payments in accordance with ASC Topic 718. Stock-based compensation expense included in Operating expenses for fiscal years 2021, 2020 and 2019 was as follows:

For the Fiscal Years Ended

  

August 28,

August 29,

August 31,

2021

2020

2019

Stock options

$

2,285

$

3,645

$

4,786

Restricted share awards

185

1,552

Restricted stock units

13,976

12,319

9,633

Performance share units

1,233

575

Associate Stock Purchase Plan

227

208

312

Total

17,721

16,932

16,283

Deferred income tax benefit

(4,324)

(4,182)

(4,006)

Stock-based compensation expense, net

$

13,397

$

12,750

$

12,277

2015 Omnibus Incentive Plan

At the Company’s annual meeting of shareholders held on January 15, 2015, the shareholders approved the MSC Industrial Direct Co., Inc. 2015 Omnibus Incentive Plan (the “2015 Omnibus Incentive Plan”). The 2015 Omnibus Incentive Plan replaced the MSC Industrial Direct Co., Inc. 2005 Omnibus Incentive Plan (the “Prior Plan”) and, beginning January 15, 2015, all awards are granted under the 2015 Omnibus Incentive Plan. Awards under the 2015 Omnibus Incentive Plan may be made in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, other share-based awards, and performance cash, performance shares or performance units. All outstanding awards under the Prior Plan will continue to be governed by the terms of the Prior Plan. Upon approval of the 2015 Omnibus Incentive Plan, the maximum aggregate number of shares of Class A Common Stock authorized to be issued under the 2015 Omnibus Incentive Plan was 5,217 shares, of which 1,432 authorized shares of Class A Common Stock were remaining as of August 28, 2021.

Stock Options

A summary of the status of the Company’s stock options at August 28, 2021 and changes during fiscal year 2021 is presented in the table and narrative below:

2021

Shares

Weighted-Average Exercise Price

Outstanding - beginning of year

1,539

$

75.76

Granted

Exercised

(401)

73.96

Canceled/Forfeited

(8)

79.63

Outstanding - end of year

1,130

$

76.38

Exercisable - end of year

890

$

74.87

The total intrinsic value of options exercised during fiscal years 2021, 2020 and 2019 was $5,826, $2,604 and $1,882, respectively. The unrecognized share-based compensation cost related to stock option expense at August 28, 2021 was $1,385 and will be recognized over a weighted average period of 0.8 years.

Stock option awards outstanding under the Company’s incentive plans have been granted at exercise prices that are equal to the market value of its Class A Common Stock on the date of grant. Such options generally vest over a period of four years and expire at seven years after the grant date. The Company recognizes compensation expense ratably over the vesting period, net of estimated forfeitures. The Company uses the Black-Scholes option-pricing model to estimate the fair value of stock options granted, which requires the input of both subjective and objective assumptions as follows:

 

Expected Term — The estimate of expected term is based on the historical exercise behavior of grantees, as well as the contractual life of the option grants.

Expected Volatility — The expected volatility factor is based on the volatility of the Company’s Class A Common Stock for a period equal to the expected term of the stock option.

 

Risk-free Interest Rate — The risk-free interest rate is determined using the implied yield for a traded zero-coupon U.S. Treasury bond with a term equal to the expected term of the stock option.

Expected Dividend Yield — The expected dividend yield is based on the Company's historical practice of paying quarterly dividends on its Class A Common Stock.

 

The Company discontinued its grants of stock options in fiscal year 2020. The Company’s weighted-average assumptions used to estimate the fair value of stock options granted during fiscal year 2019 were as follows:

2019

Expected life (in years)

4.0

Risk-free interest rate

2.98

%

Expected volatility

23.1

%

Expected dividend yield

2.70

%

Weighted-Average Grant-Date Fair Value

$

14.05

The following table summarizes information about stock options outstanding and exercisable at August 28, 2021:

Options Outstanding

Options Exercisable

Range of Exercise Prices

Number of Options Outstanding at August 28, 2021

Weighted-Average Remaining Contractual Life

Weighted-Average Exercise Price

Intrinsic Value

Number of Options Exercisable at August 28, 2021

Weighted-Average Remaining Contractual Life

Weighted-Average Exercise Price

Intrinsic Value

$ 58.90 – $ 71.33

389 

1.7

$

66.20 

$

7,449 

389 

1.7

$

66.20 

$

7,449 

71.3479.60

271 

3.2

79.60 

1,561 

190 

3.2

79.60 

1,093 

79.61 –  81.76

73 

1.2

81.76 

262 

73 

1.2

81.76 

262 

81.77 –  83.03

397 

3.4

83.16 

867 

238 

2.8

83.13 

529 

  

1,130 

2.6

$

76.38 

$

10,139 

890 

2.3

$

74.87 

$

9,333 

Performance Share Units

Beginning in fiscal year 2020, the Company granted performance share units (“PSUs”) as part of its long-term stock-based compensation program. PSUs cliff vest after a three year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from zero to 200 percent of the target award amount.

The following table summarizes all transactions related to PSUs under the 2015 Omnibus Incentive Plan (based on target award amounts) for fiscal year 2021:

2021

Shares

Weighted-Average Grant-Date Fair Value

Non-vested PSUs at the beginning of the year

28

$

76.32

Granted

31

74.79

Vested

Canceled/Forfeited

(1)

75.55

Non-vested PSUs at the end of the year (1)

58

$

75.52

(1) Excludes 8 shares of accrued incremental dividend equivalent rights on outstanding PSUs granted under the 2015 Omnibus Incentive Plan.

The fair value of each PSU is the closing stock price on the New York Stock Exchange (the “NYSE”) of the Company’s Class A Common Stock on the date of grant. Upon vesting, subject to achievement of performance goals, a portion of the PSU award may be withheld to satisfy the statutory income tax withholding obligation. The remaining PSUs will be settled in shares of the Company’s Class A Common Stock when vested. These awards accrue dividend equivalents on the underlying PSUs (in the form of additional stock units) based on dividends declared on the Company’s Class A Common Stock and these dividend equivalents are paid out in unrestricted shares of the Company’s Class A Common Stock on the vesting dates of the underlying PSUs, subject to the same performance vesting requirements. The unrecognized share-based compensation cost related to the PSUs at August 28, 2021 was $2,479 and is expected to be recognized over a period of 1.7 years.

Restricted Stock Units

A summary of the Company’s non-vested restricted stock unit (“RSU”) award activity for fiscal year 2021 is as follows:

2021

Shares

Weighted-Average Grant-Date Fair Value

Non-vested RSU awards at the beginning of the year

482

$

76.73

Granted

235

75.16

Vested

(168)

74.65

Canceled/Forfeited

(25)

76.79

Non-vested RSU awards at the end of the year (1)

524

$

76.69

(1) Excludes approximately 84 shares of accrued incremental dividend equivalent rights on outstanding RSUs granted under the 2015 Omnibus Incentive Plan.

The fair value of each RSU is the closing stock price on the NYSE of the Company’s Class A Common Stock on the date of grant. Upon vesting, a portion of the RSU award may be withheld to satisfy the statutory income tax withholding obligation. The remaining RSUs will be settled in shares of the Company’s Class A Common Stock after the vesting period. These awards accrue dividend equivalents on outstanding units (in the form of additional stock units) based on dividends declared on the Company’s Class A Common Stock and these additional RSUs are subject to the same vesting periods as the RSUs in the underlying award. The dividend equivalents are not included in the RSU table above. The unrecognized compensation cost related to the RSUs at August 28, 2021 was $28,433 and is expected to be recognized over a period of 2.6 years.

Associate Stock Purchase Plan

The Company has established a qualified Associate Stock Purchase Plan, the terms of which allow for eligible associates (as defined in the Associate Stock Purchase Plan) to participate in the purchase of up to a maximum of five shares of the Company’s Class A Common Stock at a price equal to 90% of the closing price at the end of each stock purchase period. On January 15, 2015, the shareholders of the Company approved an increase to the authorized but unissued shares of the Class A Common Stock of the Company reserved for sale under the Associate Stock Purchase Plan from 1,150 to 1,500 shares. As of August 28, 2021, approximately 347 shares remain reserved for issuance under this plan. Associates purchased approximately 57 and 69 shares of Class A Common Stock during fiscal years 2021 and 2020 at an average per share price of $72.87 and $59.71, respectively.

Savings Plan

The Company maintains a defined contribution plan with both a profit sharing feature and a 401(k) feature which covers all associates who have completed at least one month of service with the Company. For fiscal years 2021, 2020 and 2019, the Company contributed $7,952, $5,491 and $8,439, respectively, to the plan. The Company contributions are discretionary. The Company temporarily suspended the employer matching contribution to eligible participants in the Company’s 401(k) on April 13, 2020, and the matching contribution was reinstated on September 17, 2020.